- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on H. Lundbeck A/S required for business and competitor intelligence needs
A study of the major internal and external factors affecting H. Lundbeck A/S in the form of a SWOT analysis
An in-depth view of the business model of H. Lundbeck A/S including a breakdown and examination of key business segments
Intelligence on H. Lundbeck A/S’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about H. Lundbeck A/S, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
H. Lundbeck A/S (Lundbeck or 'the company') is a specialty pharmaceutical company focusing in the field of psychiatric and neurological disorders. The company's majority of operations are in the Americas and Europe. It is headquartered in Valby, Denmark and employed 5,639 people as of December 31, 2012. The company recorded revenues of DKK14,802 million ($2,556.3 million*) during the financial year ended December 2012 (FY2012), a decrease of 7.5% over FY2011. The operating profit of the company was DKK1,647 million ($284.4 million*) in FY2012, a decrease of 51.5% over FY2011. The net profit was DKK1,107 million ($191.2 million*) in FY2012, a decrease of 51.5% over FY2011. *Calculated using a constant conversion rate of DKK1 = $0.1727 for the financial year ended December 31, 2012.
Reasons to Purchase:
Gain understanding of H. Lundbeck A/S and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess H. Lundbeck A/S as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on H. Lundbeck A/S’s business structure, strategy and prospects